Polyploid Terpene Expression

Polyploid Terpene Expression refers to altered volatile compound profiles observed in cannabis plants with chromosome counts above the standard diploid (2n) level, such as triploids (3n) or tetraploids (4n). These ploidy variations can influence both terpene synthesis pathways and overall aromatic complexity, though expression patterns vary widely depending on genetic background and environmental conditions. Researchers and breeders have documented instances where polyploid specimens produce terpene ratios or minor volatile compounds that differ measurably from their diploid parent lines. However, polyploidy does not guarantee predictable or enhanced terpene profiles—outcomes depend heavily on which genes are affected and how metabolic regulation responds to the chromosomal imbalance. This classification remains an active area of cannabis breeding research, particularly for programs seek

Breeders working with induced polyploidy (via colchicine treatment or spontaneous occurrence) often monitor terpene profiles as a key marker of stability and novelty. Understanding how ploidy shifts affect terpene biosynthesis enzymes helps inform parent selection and hybrid development strategies in pursuit of distinct aromatic signatures.